⌘K

Login Start Free

Home/Filings/4/0001104659-23-039358

4//SEC Filing

KELLY JUSTYNA 4

Accession 0001104659-23-039358

CIK 0001811764other

View on SEC.gov Company Profile

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 8:11 PM ET

Size

5.4 KB

Accession

0001104659-23-039358

Insider Transaction Report

Form 4

Period: 2023-03-28

POINT Biopharma Global Inc.PNT

Chief Operating Officer

Transactions

Award
Stock Option (Right to Buy)
2023-03-28+98,358→ 98,358 total
Exercise: $6.78Exp: 2029-03-28→ Common Stock (98,358 underlying)

Footnotes (1)

[F1]The option vests 25% on the first anniversary of the date of grant with the remaining 75% vesting in three equal annual installments thereafter.

Documents

1 file

4
tm2311087-4_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

POINT Biopharma Global Inc.

CIK 0001811764

Entity typeother

Related Parties

1

filerCIK 0001898344

Filing Metadata

Form type: 4
Filed: Mar 29, 8:00 PM ET
Accepted: Mar 30, 8:11 PM ET
Size: 5.4 KB

View on SEC.gov